Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus

Journal of Gene Medicine

Volumn 7, Issue 3, 2005, Pages 316-324

  Kaspar, Brian K ^a   Roth, David M ^b,c   Lai, N Chin ^c,d   Drumm, Jeffrey D ^c   Erickson, Dawn A ^d   McKirnan, M Dan ^d   Hammond, H Kirk ^c,d  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b University of California   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

AAV; Cardiovascular gene transfer; Gene therapy; Heart; Vector

Indexed keywords

DEOXYRIBONUCLEASE; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CIRCUMFLEX BRANCH; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE TRANSFER; GENETIC CODE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART PERFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; LIVER; LUNG; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; SWINE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE; DEPENDOVIRUS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART; HUMANS; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SWINE; TISSUE DISTRIBUTION; TRANSGENES;

ADENO-ASSOCIATED VIRUS;

EID: 15944405038     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.665     Document Type: Article

References (30)

1. Flotte TR, Afione SA, Conrad C, et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci A 1993; 90: 10 613-10 617.
2. Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther 2000; 7: 24-30.
3. Podsakoff G, Wong KK, Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors, J Virol 1994; 68: 5656-5666.
4. Aikawa R, Huggins GS, Snyder RO. Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction. J Biol Chem 2002; 277: 18979-18985.
5. Asfour B, Baba HA, Scheld HH, Hruban RH, Byrne BJ. Uniform long-term gene expression using adeno-associated virus (AAV) by ex vivo recirculation in rat cardiac isografts. Thorac Cardiov Surg 2002; 50: 347-350.
6. Donahue BA, McArthur JG, Spratt SK, et al. Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med 1999; 1: 31-42.
7. Hoshijima M, Ikeda Y, Iwanaga Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nature Med 2002; 8: 864-871.
8. Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
9. Kaplitt MG, Xiao X, Samulski RJ, et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg 1996; 62: 1669-1676.
10. Kaspar BK, Vissel B, Bengoechea T, et al. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci U S A 2002; 99: 2320-2325.
11. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003; 301: 839-842.
12. Melo LG, Reitu A, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002; 105: 602-607.
13. Snyder RO, Spratt SK, Lagarde C, et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 1997; 8: 1891-1900.
14. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci U S A 2002; 99 9480-9485.
15. Svensson EC, Marshall DJ, Woodard K, et al. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 1999; 99: 201-205.
16. Tsui T-Y, Wu X, Lau C-K, et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107: 2623-2629.
17. Yasukawa H, Yajima T, Duplain H, et al. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest 2003; 111: 469-478.
18. Weitzman MD, Young SM, Cathomen T, Samulski RJ. Targeted integration by adeno-associated virus. Methods Mol Med 2003; 76 201-219.
19. Hajjar RJ, Schmidt U, Matsui T, et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A 1998; 95: 5251-5256.
20. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59-74.
21. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
22. Lai NC, Roth DM, Gao MH, et al. Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity. Circulation 2000; 102: 2396-2401.
23. Lai NC, Roth DM, Gao MH, et al. Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation 2004; 110: 330-336.
24. Iwatate M, Gu Y, Dieterle T, et al. In vivo high-efficiency transcoronary gene delivery and Cre-loxP gene switching in the adult mouse heart. Gene Ther 2003; 10: 1814-1820.
25. Wright MJ, Rosenthal E, Stewart L, et al. β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale. Gene Ther 1998; 5: 301-308.
26. Giordano F, Ping P, Nozaki S, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996; 2: 534-539.
27. Grines CL, Watkins MW, Helmer G, et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291-1297.
28. Gao MH, Lai NC, McKirnan MD, et al. Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor-4: report of preclinical data. Hum Gene Ther 2004; 15: 574-587.
29. Roth DM, Lai NC, Gao MH, et al. Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice. Am J Physiol Heart Circ Physiol 2004; 287: H172-H177.
30. Ikeda Y, Gu Y, Iwanaga Y, et al. Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation 2002; 105: 502-508.